HEPATIC IMPAIRMENT (HI)

Clinical trials for HEPATIC IMPAIRMENT (HI) explained in plain language.

Never miss a new study

Get alerted when new HEPATIC IMPAIRMENT (HI) trials appear

Sign up with your email to follow new studies for HEPATIC IMPAIRMENT (HI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

Scientists test drug safety in people with liver problems

Knowledge-focused Recruiting now

This study aims to understand how a moderate liver condition affects how the body processes a single dose of the drug nemtabrutinib. It will compare 32 participants—some with stable, moderate liver impairment and some healthy—to see how much of the drug stays in their blood and c…

Matched conditions: HEPATIC IMPAIRMENT (HI)

Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused

Last updated Mar 31, 2026 12:10 UTC

HEPATIC IMPAIRMENT (HI)

Get alerted when new HEPATIC IMPAIRMENT (HI) trials appear

Scientists test drug safety in people with liver problems